Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CryoPort, Inc. stock logo
CYRX
CryoPort
$14.71
-3.5%		$15.50
$7.51
▼
$16.89
$768.64M1.89609,870 shs634,865 shs
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$8.57
-8.6%		$8.80
$5.37
▼
$17.58
$612.09M1.78864,767 shs1.73 million shs
Evotec AG stock logo
EVO
Evotec
$1.95
-1.5%		$2.48
$1.90
▼
$4.27
$704.40M1.9689,124 shs66,781 shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$0.80
+2.0%		$0.88
$0.70
▼
$1.72
$306.09M1.42.01 million shs1.11 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CryoPort, Inc. stock logo
CYRX
CryoPort
+0.20%+2.14%+0.13%+19.51%+126.26%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-0.12%+22.98%-7.30%-9.44%-34.44%
Evotec AG stock logo
EVO
Evotec
+1.54%+2.59%-32.19%-35.08%-48.97%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-4.44%-10.28%-11.63%-21.59%-39.68%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CryoPort, Inc. stock logo
CYRX
CryoPort
$14.71
-3.5%		$15.50
$7.51
▼
$16.89
$768.64M1.89609,870 shs634,865 shs
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$8.57
-8.6%		$8.80
$5.37
▼
$17.58
$612.09M1.78864,767 shs1.73 million shs
Evotec AG stock logo
EVO
Evotec
$1.95
-1.5%		$2.48
$1.90
▼
$4.27
$704.40M1.9689,124 shs66,781 shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$0.80
+2.0%		$0.88
$0.70
▼
$1.72
$306.09M1.42.01 million shs1.11 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CryoPort, Inc. stock logo
CYRX
CryoPort
+0.20%+2.14%+0.13%+19.51%+126.26%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-0.12%+22.98%-7.30%-9.44%-34.44%
Evotec AG stock logo
EVO
Evotec
+1.54%+2.59%-32.19%-35.08%-48.97%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-4.44%-10.28%-11.63%-21.59%-39.68%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CryoPort, Inc. stock logo
CYRX
CryoPort
2.75
Moderate Buy$16.4311.68% Upside
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
1.67
Reduce$8.50-0.76% Downside
Evotec AG stock logo
EVO
Evotec
2.20
Hold$3.0053.85% Upside
Standard BioTools Inc. stock logo
LAB
Standard BioTools
1.67
Reduce$1.3568.73% Upside

Current Analyst Ratings Breakdown

Latest LAB, CYRX, EVO, and DNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
7/24/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$17.00 ➝ $25.00
7/21/2026
Evotec AG stock logo
EVO
Evotec
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/21/2026
Standard BioTools Inc. stock logo
LAB
Standard BioTools
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
7/17/2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/16/2026
Evotec AG stock logo
EVO
Evotec
Berenberg Bank logo
Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
7/15/2026
Evotec AG stock logo
EVO
Evotec
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$7.00 ➝ $4.00
7/15/2026
Evotec AG stock logo
EVO
Evotec
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$2.00
6/8/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$13.50
6/8/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$13.00
6/3/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $20.00
(Data available from 8/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CryoPort, Inc. stock logo
CYRX
CryoPort
$176.18M4.21N/AN/A$9.19 per share1.60
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$170.15M3.29N/AN/A$8.74 per share0.98
Evotec AG stock logo
EVO
Evotec
$891.97M0.78N/AN/A$2.59 per share0.75
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$85.33M3.66N/AN/A$1.10 per share0.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CryoPort, Inc. stock logo
CYRX
CryoPort
$78.30M$1.3510.90N/AN/A41.57%-7.92%-4.79%8/6/2026 (Estimated)
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$312.76M-$5.36N/AN/AN/A-215.41%-56.08%-26.06%N/A
Evotec AG stock logo
EVO
Evotec
-$117.12MN/AN/AN/AN/A-26.20%-24.93%-11.35%8/13/2026 (Estimated)
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$74.90M$0.223.64N/AN/A100.36%-7.89%-6.26%N/A

Latest LAB, CYRX, EVO, and DNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Evotec AG stock logo
EVO
Evotec
-$0.0461N/AN/AN/A$173.90 millionN/A
8/6/2026Q2 2026
CryoPort, Inc. stock logo
CYRX
CryoPort
-$0.1933-$0.20-$0.0067-$0.20$48.18 million$48.97 million
8/5/2026Q2 2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$0.8950-$0.75+$0.1450-$0.75$24.05 million$20.16 million
5/7/2026Q1 2026
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
-$1.2112-$1.39-$0.1789-$1.39$42.93 million$19.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CryoPort, Inc. stock logo
CYRX
CryoPort
N/AN/AN/AN/AN/A
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/AN/AN/AN/AN/A
Evotec AG stock logo
EVO
Evotec
N/AN/AN/AN/AN/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CryoPort, Inc. stock logo
CYRX
CryoPort
N/A
2.09
2.00
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
N/A
5.15
5.15
Evotec AG stock logo
EVO
Evotec
0.43
1.68
1.60
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/A
12.36
11.92

Institutional Ownership

CompanyInstitutional Ownership
CryoPort, Inc. stock logo
CYRX
CryoPort
92.90%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
78.63%
Evotec AG stock logo
EVO
Evotec
5.81%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.74%

Insider Ownership

CompanyInsider Ownership
CryoPort, Inc. stock logo
CYRX
CryoPort
9.50%
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
12.69%
Evotec AG stock logo
EVO
Evotec
1.00%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
26.81%
CompanyEmployeesShares OutstandingFree FloatOptionable
CryoPort, Inc. stock logo
CYRX
CryoPort
1,18650.40 million45.61 millionOptionable
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
64065.32 million57.03 millionOptionable
Evotec AG stock logo
EVO
Evotec
4,553355.76 million352.20 millionNot Optionable
Standard BioTools Inc. stock logo
LAB
Standard BioTools
620390.37 million285.71 millionOptionable

Recent News About These Companies

Standard BioTools: Q2 Earnings Snapshot
August 6 at 12:17 PM  |  aol.comA
Standard BioTools (NASDAQ:LAB) Issues Earnings Results
August 5 at 5:55 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/standard-biotools-nasdaqlab-issues-earnings-results-2026-08-05/
Standard BioTools Reports Second Quarter 2026 Financial Results
August 5 at 4:05 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339662/0/en/standard-biotools-reports-second-quarter-2026-financial-results.html
Standard BioTools Inc. (NASDAQ:LAB) Short Interest Update
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/standard-biotools-inc-nasdaqlab-short-interest-update-2026-07-31/
Standard BioTools (LAB) to Release Earnings on Wednesday
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/standard-biotools-lab-to-release-earnings-on-wednesday-2026-07-29/
Standard BioTools Announces Sale of Mass Cytometry Business and Illumina's Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
July 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334170/0/en/standard-biotools-announces-sale-of-mass-cytometry-business-and-illumina-s-buyout-of-contingent-payments-to-advance-merger-with-treeline-biosciences.html
Standard Biotools CFO Kim Hanjoon Alex Executes Stock Withholding of Over 202,000 Shares Due to RSU Vesting
July 27, 2026  |  kalkinemedia.comK
Standard BioTools Inc.
July 25, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/lab/company-profile
Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/22/3331217/0/en/standard-biotools-to-announce-second-quarter-2026-financial-results-on-august-5-2026.html
Amova Asset Management Americas Inc. Lowers Stock Position in Standard BioTools Inc. $LAB
July 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-amova-asset-management-americas-inc-lowers-stock-position-in-standard-biotools-inc-lab-2026-07-22/
Standard BioTools Inc.: Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
July 20, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/69070845-standard-biotools-inc-standard-biotools-announces-filing-of-registration-statement-in-connection-with-treeline-biosciences-transaction-399.htm
Standard BioTools Files S-4 for Merger with Treeline Biosciences, Highlighting Promising TLN-121 Clinical Data and Strong Cash Position
July 20, 2026  |  quiverquant.comQ
Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
July 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/20/3329639/0/en/standard-biotools-announces-filing-of-registration-statement-in-connection-with-treeline-biosciences-transaction.html
Standard BioTools Inc. $LAB Shares Sold by Sumitomo Mitsui Trust Group Inc.
July 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-standard-biotools-inc-lab-shares-sold-by-sumitomo-mitsui-trust-group-inc-2026-07-17/
Standard BioTools Shareholders Approve 2026 Equity Incentive Plans
June 18, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/standard-biotools-shareholders-approve-2026-equity-incentive-plans?utm_source=marketbeat.com&utm_medium=referral
LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders
June 16, 2026  |  tmcnet.comhttps://www.tmcnet.com/usubmit/2026/06/15/10399754.htm
Labrador Gold Announces 2026 Exploration Plans for Pacific Ridge's White Gold Projects
June 11, 2026  |  newsfilecorp.comN
Labrador Gold to Host Investor Webinar on the Mariposa Gold Project in Yukon's White Gold District
June 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/11/3310330/0/en/labrador-gold-to-host-investor-webinar-on-the-mariposa-gold-project-in-yukon-s-white-gold-district.html
Standard BioTools Inc. (LAB) Discusses Merger and Strategic Rationale Prepared Remarks Transcript
June 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4913105-standard-biotools-inc-lab-discusses-merger-and-strategic-rationale-prepared-remarks
Standard BioTools Inc.: Standard BioTools and Treeline Biosciences Announce Merger Agreement
June 8, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-06/68706821-standard-biotools-inc-standard-biotools-and-treeline-biosciences-announce-merger-agreement-399.htm
Standard BioTools and Treeline Biosciences Announce Merger Agreement
June 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/08/3307989/0/en/standard-biotools-and-treeline-biosciences-announce-merger-agreement.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Rocket Lab Electron rocket on coastal launch pad with company logo overlay, symbolizing space tech integration strategy.
Rocket Lab’s Stock Drop Comes With a Bullish Twist
By Ryan Hasson | July 10, 2026
Abbott logo displayed on a glass office building exterior at the company's headquarters.
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
By Thomas Hughes | July 16, 2026
Illustration of a space station with solar panels orbiting Earth against a starry background.
3 Space Stocks That Could Outshine SpaceX After Its IPO
By Chris Markoch | July 14, 2026
AST SpaceMobile logo above a satellite in orbit over Earth, highlighting space-based wireless expansion.
AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
By Jessica Mitacek | July 17, 2026
Illustration of colorful fiber optic cables feeding into a metal connector labeled "AI Co." inside a data center.
Beyond the Foundry: 5 Infrastructure Stocks Tackling the AI Bottlenecks
By Thomas Hughes | July 14, 2026
CryoPort stock logo

CryoPort NASDAQ:CYRX

$14.71 -0.54 (-3.54%)
Closing price 04:00 PM Eastern
Extended Trading
$15.39 +0.68 (+4.62%)
As of 06:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Ginkgo Bioworks stock logo

Ginkgo Bioworks NYSE:DNA

$8.56 -0.81 (-8.59%)
Closing price 03:59 PM Eastern
Extended Trading
$8.54 -0.02 (-0.23%)
As of 06:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Evotec stock logo

Evotec NASDAQ:EVO

$1.95 -0.03 (-1.52%)
Closing price 04:00 PM Eastern
Extended Trading
$1.94 -0.01 (-0.72%)
As of 05:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer; and Inserm, the French National Institute of Health and Medical Research, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases, as well as collaboration with CHDI Foundation, Inc.; and a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic, as well as research collaboration with Pfizer for metabolic and infectious diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Standard BioTools stock logo

Standard BioTools NASDAQ:LAB

$0.80 +0.02 (+2.04%)
Closing price 04:00 PM Eastern
Extended Trading
$0.80 -0.01 (-0.64%)
As of 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas